Scale Biosciences

San Diego, United States Founded: 2020 • Age: 6 yrs Acquired By 10X Genomics
Scale Biosciences is a company developing single-cell library preparation kits for genomic, epigenomic, and transcriptomic analysis.

About Scale Biosciences

Scale Biosciences is a Healthcare company based in San Diego (United States) founded in 2020 by Frank Steemers, and was acquired by 10X Genomics in August 2025. Scale Biosciences is a company developing single-cell library preparation kits for genomic, epigenomic, and transcriptomic analysis. Its chief executive, as recorded, is Giovanna Prout. Its website scale.bio draws about 11 thousand monthly visits.

Company details

Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.

  • Headquarters San Diego, United States
  • Founders Frank Steemers
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website scale.bio
  • Social LinkedIn X
  • Acquired by 10X Genomics (Aug 2025)
Key Metrics

Investors in Scale Biosciences

Scale Biosciences has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.

All
InvestorDescriptionFounded YearDomainLocation
Instrument systems for genomic research and sequencing libraries are developed.
201210xgenomics.comPleasanton, United States
Premium access

Investor details for Scale Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Scale Biosciences

14 people are tracked at Scale Biosciences (4 in leadership, 10 in team).

NameRoleGroup
Frank Steemers
Co-FounderLeadership
Giovanna Prout
CEOLeadership
Melanie Masuda
Director, Market DevelopmentLeadership
Keith Jackson
Head Of Product ManagementLeadership
Bryce Alves
Staff ScientistTeam
Tushar Shah
Senior Sales SpecialistTeam
Nicholas Pervolarakis, PhD
Senior Bioinformatics ScientistTeam
Phuong Dang
ScientistTeam
Qiang Li
Sr. Staff ScientistTeam
Kristin Kelley
Sr. Sales SpecialistTeam
Amy Hamilton
Global Marketing Programs ManagerTeam
Jennifer Michaud
Production ManagerTeam
Katharina Danielski
Senior Field Application ScientistTeam
Sanika Khare
Application ScientistTeam
Premium access

Complete people profiles for Scale Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Scale Biosciences

2 dated milestones of Scale Biosciences across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Scale Biosciences is founded.
  2. Exit Acquired by 10X Genomics.

Web traffic of Scale Biosciences

The website of Scale Biosciences (scale.bio) receives about 11.3K visits a month.

  • Monthly visits
    11.3K

    ▲ 19.5% vs previous month

Similar websites

Websites whose visitors overlap most with Scale Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
parsebiosciences.com
100%
62.7K#493,988View details
cellecta.com
84%
16.5K#1,583,800View details
nature.com
80%
33.6M#1,922View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Scale Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Scale Biosciences

Premium access

Complete news archive for Scale Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Scale Biosciences

Scale Biosciences was founded in 2020.

Scale Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Giovanna Prout is the CEO of Scale Biosciences, as recorded in our data.

Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.

Scale Biosciences has 1 investor. Key investors include 10X Genomics.

Yes. Scale Biosciences was acquired by 10X Genomics in August 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available